News on Intas Pharmaceuticals Ltd from BioPortfolio.com http://www.BioPortfolio.com Consolidated Intas Pharmaceuticals Ltd news from BioPortfolio.com Wed, 10 Feb 2010 00:06:57 GMT en Bionomics of Biosimilarshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4011695&HITNO=0&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Intas%20Pharmaceuticals%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4011695&THISHREF=http://c.moreover.com/click/here.pl%3fz2523070234%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4011695&HITNO=0&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Intas%20Pharmaceuticals%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4011695&THISHREF=http://c.moreover.com/click/here.pl%3fz2523070234%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBio Spectrum Asia: Obama push for lower data exclusivity for biosimilars to boost hopes for Indiahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3997276&HITNO=1&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Intas%20Pharmaceuticals%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3997276&THISHREF=http://c.moreover.com/click/here.pl%3fz2516625416%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3997276&HITNO=1&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Intas%20Pharmaceuticals%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3997276&THISHREF=http://c.moreover.com/click/here.pl%3fz2516625416%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBio Spectrum Asia: Intas Biopharma to focus on developing biosimilars for US, EUhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3989201&HITNO=2&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Intas%20Pharmaceuticals%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3989201&THISHREF=http://c.moreover.com/click/here.pl%3fz2512075887%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3989201&HITNO=2&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Intas%20Pharmaceuticals%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3989201&THISHREF=http://c.moreover.com/click/here.pl%3fz2512075887%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBusiness Standard India: Indian bio-pharma industry accounts for 65% of the biotech sectorhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3986688&HITNO=3&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Intas%20Pharmaceuticals%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3986688&THISHREF=http://c.moreover.com/click/here.pl%3fz2509329426%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3986688&HITNO=3&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Intas%20Pharmaceuticals%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3986688&THISHREF=http://c.moreover.com/click/here.pl%3fz2509329426%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaBiz: Intas Biopharmaceuticals win GOLD award for Quality Excellencehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3975697&HITNO=4&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Intas%20Pharmaceuticals%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3975697&THISHREF=http://c.moreover.com/click/here.pl%3fz2504132781%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3975697&HITNO=4&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Intas%20Pharmaceuticals%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3975697&THISHREF=http://c.moreover.com/click/here.pl%3fz2504132781%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comI-Newswire: Abbott declares quarterly dividend of 40 cents per sharehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3969583&HITNO=5&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Intas%20Pharmaceuticals%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3969583&THISHREF=http://c.moreover.com/click/here.pl%3fz2500893075%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3969583&HITNO=5&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Intas%20Pharmaceuticals%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3969583&THISHREF=http://c.moreover.com/click/here.pl%3fz2500893075%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: Intas Biopharma wins GOLD award for Quality Excellencehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3972522&HITNO=6&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Intas%20Pharmaceuticals%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3972522&THISHREF=http://c.moreover.com/click/here.pl%3fz2502449392%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3972522&HITNO=6&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Intas%20Pharmaceuticals%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3972522&THISHREF=http://c.moreover.com/click/here.pl%3fz2502449392%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Intas Biopharmaceuticals win GOLD award for Quality Excellencehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3972517&HITNO=7&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Intas%20Pharmaceuticals%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3972517&THISHREF=http://c.moreover.com/click/here.pl%3fz2502446434%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3972517&HITNO=7&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Intas%20Pharmaceuticals%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3972517&THISHREF=http://c.moreover.com/click/here.pl%3fz2502446434%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Intas Biopharmaceuticals gets award qualityhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3968615&HITNO=8&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Intas%20Pharmaceuticals%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3968615&THISHREF=http://c.moreover.com/click/here.pl%3fz2500443068%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3968615&HITNO=8&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Intas%20Pharmaceuticals%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3968615&THISHREF=http://c.moreover.com/click/here.pl%3fz2500443068%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBio Spectrum Asia: Express Pharma organizes Knowledge Exchange in association with IBMhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3878503&HITNO=9&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Intas%20Pharmaceuticals%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3878503&THISHREF=http://c.moreover.com/click/here.pl%3fz2452305859%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3878503&HITNO=9&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Intas%20Pharmaceuticals%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3878503&THISHREF=http://c.moreover.com/click/here.pl%3fz2452305859%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comExpress Pharma: Novartis to leapfrog Alcon dealhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3877947&HITNO=10&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Intas%20Pharmaceuticals%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3877947&THISHREF=http://c.moreover.com/click/here.pl%3fz2452119250%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3877947&HITNO=10&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Intas%20Pharmaceuticals%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3877947&THISHREF=http://c.moreover.com/click/here.pl%3fz2452119250%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFinancial Express: Novartis to leapfrog Alcon dealhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3875077&HITNO=11&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Intas%20Pharmaceuticals%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3875077&THISHREF=http://c.moreover.com/click/here.pl%3fz2450838065%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3875077&HITNO=11&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Intas%20Pharmaceuticals%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3875077&THISHREF=http://c.moreover.com/click/here.pl%3fz2450838065%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comExpress India: Orbus Pharma to sell product rights for $2.5-millionhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3662329&HITNO=12&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Intas%20Pharmaceuticals%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3662329&THISHREF=http://c.moreover.com/click/here.pl%3fz2345077047%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3662329&HITNO=12&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Intas%20Pharmaceuticals%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3662329&THISHREF=http://c.moreover.com/click/here.pl%3fz2345077047%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStockwatch: